Arthur Sillah, n/a

Director, RWE
Jazz Pharmaceuticals Plc, Dublin, Ireland, Ireland

Poster(s):

• (225) Treatment Patterns, Healthcare Resource Utilization (HCRU), and Costs in Adolescent and Young Adult (AYA) Patients (Pts) With Acute Lymphoblastic Leukemia (ALL)
  Wednesday, October 29, 2025